Join company to edit the org chart
Cantargia logo

Cantargia

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.

Org chart

Göran Forsberg
CEO
Göran Forsberg
Göran Forsberg
Collapse
Bengt Jöndell
CFO
Bengt Jöndell
David Liberg
VP Cancer Research
David Liberg
Ignacio Garcia-Ribas
CMO
Ignacio Garcia-Ribas
Lars Thorsson
VP Clinical Development
Lars Thorsson
Liselotte Larsson
VP Operations
Liselotte Larsson

Board & Advisors

Anders Martin-Löf
Board Member
Anders Martin-Löf
Claus Asbjørn Andersson
Board Member
Claus Asbjørn Andersson
Karin Leandersson
Board Member
Karin Leandersson
Magnus Persson
Chairman
Magnus Persson
Patricia Delaite
Board Member
Patricia Delaite
Thoas Fioretos
Board Member
Thoas Fioretos
Cantargia logo

Cantargia

Icon showing two mini team announcements

Team announcements

Announce a recent hire, promotion or personnel change at your company

Read more
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.